z-logo
open-access-imgOpen Access
Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells
Author(s) -
FIEBICH Bernd L.,
JÄGER Birgit,
SCHÖLLMANN Claudia,
WEINDEL Karin,
WILTING Jörg,
KOCHS Georg,
MARMÉ Dieter,
HUG Hubert,
WEICH Herbert A.
Publication year - 1993
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1111/j.1432-1033.1993.tb19865.x
Subject(s) - insect , microbiology and biotechnology , vascular endothelial growth factor , biology , chemistry , vegf receptors , botany , cancer research
Vascular endothelial growth factor (VEGF) is an angiogenic growth factor with a target‐cell specificity highly restricted to vascular endothelial cells. Recombinant baculovirus were constructed for the production of two different forms of the human VEGF protein in insect cells. VEGF 165 and VEGF 121 proteins produced by Sf158 cells underwent a similar processing compared with mammalian cells, including efficient glycosylation, formation of a disulfide‐linked dimer and secretion into the media. Only one of these forms, VEGF 165 had a high affinity for heparin and this characteristic was used to purify this form to homogenicity by a two‐step heparin‐affinity chromatcgraphy. The biological activity of the purified 43‐kDa homodimer was demonstrated by high‐affinity binding to VEGF receptors, and by the induction of DNA synthesis in vascular endothelial cells. A positive angiogenic activity in vivo was demonstrated by the day‐13 chorioallantoic‐membrane assay. The mitogenic potency of VEGF 121 for human umbilical vein endothelial cells was very similar compared to VEGF 165 . These results demonstrate that an angiogenic growth factor whose normal processing requires glycosylation and disulfide‐bridge formation can be efficiently expressed in high concentration (up to 5 μg/ml) in insects cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here